IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance Sheet
As of 2024-12-31
Balance Sheet
As of 2024-12-31
Swipe to see the full flow
Chart details
IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance Sheet
Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 3,293,443,000 US dollars
- Current assets
- 1,399,897,000 US dollars
- Non-current assets
- 1,893,546,000 US dollars
- Liabilities
- 1,698,130,000 US dollars
- Current liabilities
- 1,067,916,000 US dollars
- Non-current liabilities
- 630,214,000 US dollars
- Equity
- 1,595,313,000 US dollars
- Accounts receivable, net of allowance of $12,585 in 2024 and $9,501 in 2023
- 473,575,000 US dollars
- Inventories
- 381,877,000 US dollars
- Cash and cash equivalents
- 288,266,000 US dollars
- Other current assets
- 256,179,000 US dollars
- Property and equipment, net
- 713,123,000 US dollars
- Other long-term assets
- 547,518,000 US dollars
- Goodwill
- 405,100,000 US dollars
- Operating lease right-of-use assets
- 116,129,000 US dollars
- Intangible assets, net
- 111,676,000 US dollars
- Accrued liabilities
- 502,119,000 US dollars
- Credit facility
- 250,000,000 US dollars
- Current portion of long-term debt
- 167,787,000 US dollars
- Accounts payable
- 114,211,000 US dollars
- Current portion of deferred revenue
- 33,799,000 US dollars
- Long-term debt, net of current portion
- 449,786,000 US dollars
- Long-term operating lease liabilities, net of current portion
- 97,836,000 US dollars
- Other long-term liabilities
- 44,341,000 US dollars
- Long-term deferred revenue, net of current portion
- 26,939,000 US dollars
- Deferred income tax liabilities
- 11,312,000 US dollars
- Retained earnings
- 5,332,438,000 US dollars
- Additional paid-in capital
- 1,673,863,000 US dollars
- Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,836 shares in 2024 and 107,506 shares in 2023; Outstanding: 81,604 shares in 2024 and 83,032 shares in 2023
- 10,784,000 US dollars
- Deferred stock units: Outstanding: 60 units in 2024 and 59 units in 2023
- 5,885,000 US dollars
- Treasury stock, at cost: 26,232 shares in 2024 and 24,474 shares in 2023
- negative 5,334,012,000 US dollars
- Accumulated other comprehensive loss
- negative 93,645,000 US dollars
- Gross equity (calculated)
- 7,022,970,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
